Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma

NCT02502370 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Small Bowel Adenocarcinoma
Adjuvant Chemotherapy for SBA

Interventions

DRUG: observation alone
DRUG: LV5FU2
DRUG: FOLFOX

Sponsor

Centre Hospitalier Universitaire Dijon